No Data
Blood Collection Devices Market Worth $13.02 Billion by 2030 With 7.4% CAGR | MarketsandMarkets
$144.85 Bn Disposable Medical Device Markets, 2025-2030: Opportunities in Innovation in Sustainable Materials, and Expansion in Emerging Markets and Underserved Regions
The Nikkei Average closed 1,085 yen higher at its peak, led by Advantest and Fast Retailing, which have high index contribution levels, as of the afternoon session on the 31st.
On the afternoon of the 31st, the Nikkei Stock Average closed significantly higher for the third consecutive day, rising by 1,085.73 yen from the previous day to reach 52,411.34 yen. The TOPIX (Tokyo Stock Price Index) also increased by 31.04 points to close at 3,331.83 points. The Nikkei Average closed at its highest level ever, marking a new all-time closing high for two consecutive days, while the TOPIX also reached a record closing high. Investors reacted positively to the earnings reports of Apple and Amazon, released after the close of regular trading in the U.S. on the 30th. Japanese stocks saw buying interest from the morning, continuing throughout the session.
The Nikkei Average rose by approximately 860 yen, driven by positive sentiment toward Apple and Amazon's earnings reports, reaching a new intraday high for the second consecutive day as of the morning session on the 31st.
At around 10 a.m. on the 31st, the Nikkei Stock Average was trading approximately 860 yen higher than the previous day, at around 52,190 yen. At 9:50 a.m., the index reached 52,391.45 yen, up 1,065.84 yen from the previous day, marking a new intraday record high for two consecutive days (surpassing the previous record of 51,657.28 yen). On the 30th, in the U.S. stock market, Meta (formerly Facebook) and Microsoft announced plans to expand investments in AI (artificial intelligence) on the 29th local time, which heightened concerns about excessive investment.
UAE Interventional Cardiology Devices Forecast Report 2025: Market to Expand by Over $20 Billion by 2030 - Opportunities in Innovative Device Development, Government Initiatives, and Medical Tourism
Terumo Completes $1.5B Acquisition of OrganOx